AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Shaman Positioned to Provide Natural Medicine Alternatives.
Business Editors/Health & Medical Writers
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--August 22, 2000
Shaman Pharmaceuticals, Inc. (OTCBB:SHPH.OB) today announced that in light of recent Food and Drug Administration (FDA) warnings concerning using certain drugs currently on the market to relieve irritable bowel syndrome (IBS) and products widely used to lose weight that contain ephedrine, Shaman is uniquely well positioned to offer safe and natural alternatives to the unmet healthcare needs of major health communities.
Irritable Bowel Syndrome Products. The Food and Drug Administration (FDA) has begun a campaign to warn consumers of the serious potential side effects of a drug formulated to treat irritable bowel syndrome (IBS), such as Lotronex by Glaxo Wellcome. The FDA has also begun efforts to educate…
- Shaman Announces Launch of Direct-Sell Cable Program for Line Extension Product...
- Press release article from: Business Wire July 27, 2000 700+ words
...National Sales Manager, NSF-IB. "With NSF-IB, we are addressing the needs of...long-term purchase plans. NSF-IB also has a money-back guarantee...s plans to introduce its first weight loss product, a non-ephedrine based...
- Manhattan Pharmaceuticals Initiates Patient Dosing in Phase Ib Oleoyl Estrone...
- Press release article from: Business Wire May 4, 2005 700+ words
...begun patient dosing in the Phase Ib trial to evaluate the safety...the Phase Ia trial, the Phase Ib trial will be conducted in Basel...The recently commenced Phase Ib trial is a repeat-dose, dose...studies, to cause significant weight loss and reduced caloric consumption...
- Phase Ib trial of anti-obesity drug initiated.
- Newspaper article from: Clinical Trials Week August 23, 2004 700+ words
...that it has initiated a phase Ib clinical trial of APD356, its...compound. The purpose of this phase Ib study is to evaluate safety at...the United States. The phase Ib clinical trial should be completed...to play an important role in weight loss. APD356 has approximately 100...
- DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947.
- Press release article from: PR Newswire August 9, 2007 700+ words
...PK) today announced Phase Ib results for DOV 21,947, its...days. The goal of this Phase Ib study was to confirm DOV 21...placebo-controlled Phase Ib study enrolled 46 male and female...947 produced a significant weight loss in two animal models of diet...
- Manhattan's obesity drug enters Ph Ib.(pharmaceutical industry)(Brief Article)
- Newspaper article from: Pharma Marketletter May 16, 2005 700+ words
...has begun dosing in the Phase Ib trial evaluating the safety...obese adults. The new Phase Ib study is repeat-dose and dose...with an average of 8%-10% weight loss in the first year. Orally...have demonstrated significant weight loss in preclinical animal studies...
- Genaera presents preliminary Phase Ib data for Trodusquemine.
- News wire article from: Chemical Business Newsbase February 10, 2009 700+ words
...promising preliminary Phase Ib clinical data for trodusquemine...provided early indicators of weight loss and improved glucose control...which demonstrated significant weight loss without metabolic rebound, which often limits sustained weight loss during caloric restriction...
- Genaera begins Phase Ib trial of trodusquemine (MSI-1436) in overweight and...
- News wire article from: Chemical Business Newsbase December 1, 2008 700+ words
...the multiple ascending dose Phase Ib study of trodusquemine (MSI-1436...and insulin sensitivity, satiety and weight loss. The company hopes that Study 102 will...pharmacokinetics, produced dose-dependent weight loss and improved insulin sensitivity. Study...
- Dosing begins in Ph Ib trial of Genaera's trodusquemine.
- Newspaper article from: Pharma Marketletter December 8, 2008 700+ words
...102, a multiple ascending-dose Phase Ib trial of trodusquemine (MSI-1436...and insulin sensitivity, satiety and weight loss. "We hope that Study 102 will help establish...linear PK, produced dose-dependent weight loss and improved insulin sensitivity," he...
- IB Blog Center.(IBmag.com: the Web)
- Magazine article from: Inside Business February 1, 2008 700+ words
Opinions and observations continue to fly at IB's Blog Center. In January, our editors analyzed the Ohio...mothers and also looked at a normal working guy's approach to weight loss. Don't like what we have to say? Let us know!
- Scientists at Bowling Green State University report research in weight loss.
- Newspaper article from: Obesity & Diabetes Week August 25, 2008 700+ words
...States report (see also Weight Loss). "Participants who...group-based behavioral weight loss program ( BWLP) with...their total body weight (Ib) during the minimal assistance...did not improve their weight loss," wrote R.A. Carels...
Source: HighBeam Research, Shaman Positioned to Provide Natural Medicine Alternatives.
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA
The AccessMyLibrary advertising network includes:
